ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma.
Saved in:
| Title: | ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma. |
|---|---|
| Authors: | Okada R; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Mendoza A; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Nousome D; Advanced Biomedical Computational Science, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Mathur S; Advanced Biomedical Computational Science, National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Rodriguez C; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Oh J; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Pendo K; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Phadke I; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Qin H; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Singh SS; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Kaplan R; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Del Rivero J; Division of Medical Oncology, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA., Wedekind MF; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Edmondson EF; National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Miettinen M; Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA., Wilson KM; National Center for Advancing Translational Sciences, Bethesda, Maryland, USA., Lin S; National Center for Advancing Translational Sciences, Bethesda, Maryland, USA., Gomba GY; National Center for Advancing Translational Sciences, Bethesda, Maryland, USA., Holland DO; National Center for Advancing Translational Sciences, Bethesda, Maryland, USA., Das S; National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; NCI, Frederick, Maryland, USA., Rudloff U; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Andresson T; National Cancer Institute Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Chih-Chien Cheng K; National Center for Advancing Translational Sciences, Bethesda, Maryland, USA., Zhang X; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Reilly KM; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Widemann B; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Nguyen R; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA hongharosa.nguyen@nih.gov. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jul 01; Vol. 14 (7). Date of Electronic Publication: 2026 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
